- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01804751
Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China
August 24, 2015 updated by: Xinghui Liu, West China Second University Hospital
The purpose of this study is to build a model for the prediction of adverse perinatal outcome for preeclampsia in china
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Chinese women who fulfilled a research definition of preeclampsia, and who were admitted to participating obstetric centres
Description
Inclusion Criteria:
- admitted with preeclampsia or had developed preeclampsia after admission
Exclusion Criteria:
- admitted in spontaneous labour or had achieved any component of the maternal outcome before either fulfilling eligibility criteria or collection of predictor data
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
maternal mortality
Time Frame: within 48h of eligibility
|
within 48h of eligibility
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
serious central nervous system morbidity
Time Frame: within 48h of eligibility
|
within 48h of eligibility
|
|
serious cardiorespiratory morbidity
Time Frame: within 48h of eligibility
|
within 48h of eligibility
|
|
serious hepatic morbidity.
Time Frame: within 48h of eligibility
|
within 48h of eligibility
|
|
serious renal morbidity
Time Frame: within 48h of eligibility
|
within 48h of eligibility
|
|
serious haematological morbidity
Time Frame: within 48h of eligibility
|
within 48h of eligibility
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Anticipated)
December 1, 2016
Study Registration Dates
First Submitted
March 1, 2013
First Submitted That Met QC Criteria
March 1, 2013
First Posted (Estimate)
March 5, 2013
Study Record Updates
Last Update Posted (Estimate)
August 25, 2015
Last Update Submitted That Met QC Criteria
August 24, 2015
Last Verified
June 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- hx2ck2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preeclampsia
-
Comanche BiopharmaRecruitingPreeclampsia | Preterm Preeclampsia | sFlt1 Mediated Preterm PreeclampsiaAustralia
-
MemorialCare Health SystemActive, not recruitingPreeclampsia | Preeclampsia Postpartum | Preeclampsia Severe | Preeclampsia MildUnited States
-
Christiana Care Health ServicesTerminatedPre-Eclampsia | Preeclampsia | Preterm | Preeclampsia Severe | Preeclampsia Second Trimester | Preeclampsia Complicating Childbirth | Preeclampsia PuerperiumUnited States
-
University Medical Centre LjubljanaCompletedPreeclampsia Postpartum | Preeclampsia SevereSlovenia
-
Anna Stanhewicz, PhDActive, not recruiting
-
Cedars-Sinai Medical CenterThermoFisher Scientific Brahms Biomarkers FranceCompletedGestational Hypertension | Preeclampsia Severe | Preeclampsia and Eclampsia | Chronic Hypertension in Obstetric Context | Superimposed Pre-Eclampsia | Preeclampsia MildUnited States
-
Saint Thomas Hospital, PanamaRecruitingPreeclampsia | Severe PreeclampsiaPanama
-
Alexander HarrisonNot yet recruitingPreeclampsia Postpartum | Preeclampsia SevereUnited States
-
Washington University School of MedicineCompletedPreeclampsia Postpartum | Preeclampsia SevereUnited States